leisure time -WSS

leisure time

author：leisure time 2025-10-06 12:04:12 - browse：2684

Adam's take main illustration — Molly Ferguson/STAT

Cassava Sciences has long claimed its experimental drug, called simufilam, slows the cognitive decline of people with Alzheimer’s. On Friday, we learned how: The company recruited a large number of people into its clinical trial who don’t have Alzheimer’s.

People who almost certainly had Alzheimer’s were also included in the study, but in this group, a placebo outperformed Cassava’s drug.

The conclusion, of course, is obvious: Simufilam is inactive. It’s an inert compound no more effective than a placebo. Cassava’s assertion that simufilam is showing “disease-modifying activity” falls apart given its study was opened to people who should have been ineligible because they were misdiagnosed with Alzheimer’s. Whether that was done intentionally or unwittingly isn’t known, but it’s certainly troubling and makes the case for immediate, regulatory intervention even stronger.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Malaysia cuts short music fest after British band slams anti

hotspot

WSS

'Insanity': 4th of July mass shootings across US kill 13, injure more than 80

Novartis develops a rapidly manufactured CAR

Woman found dead after suspected bear encounter near Yellowstone, wildlife officials say

How a key Senate committee is planning to regulate PBMs

Pentagon will tighten controls on classified information after Discord leak

Doctors have an ethical obligation to be advocates

hotspot

leisure time

Wikipedia

New air purifier tech could be key to improving indoor air quality

Hundreds of thousands march in Israel. Former security chiefs beg Netanyahu to halt legal overhaul

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Men with early prostate cancer can safely opt out of treatment

United colonoscopy coverage change 'may cost lives,' doctors say

Accuser says Kevin Spacey grope wasn't a caress: ‘It was like a cobra ... angry’

Psychedelics group wrestles with new pharma identity

Condition critical? Britain's beloved but battered National Health Service turns 75

Anesthesiologist group: stop taking Ozempic before surgery

Novartis develops a rapidly manufactured CAR

focus

China dismisses criticism of top diplomat's comments appearing to push for race

China dismisses criticism of top diplomat's comments appearing to push for race

Pope Francis asks Church to identify 21st

Philadelphia mass shooting: Few answers in apparently random attack as suspect charged with murder

How a key Senate committee is planning to regulate PBMs

PrEP can help anyone prevent HIV. Why do so few people take it?

focus

entertainment

hotspot

focus